

TOP NEWS: Hikma Pharmaceuticals Hikes Dividend 14% As Earnings Climb


* H1 core operating profit up 15% to $284 million* Raises sales forecast for two main divisions* Signs deal to manufacture Gilead's remdesivir* Profit...


(Sharecast News) - Hikma Pharmaceuticals lifted sales guidance for its injectables business on the back of higher demand for key medicines during the ...


UK Earnings, Trading Statements Calendar - Next 7 Days


(Sharecast News) - Unite Group: Peel Hunt upgrades to add with a target price of 1,000.0p.


UK BROKER RATINGS SUMMARY: Morgan Stanley Raises Hikma To Overweight


LONDON MARKET OPEN: Stocks Fall After Strong Rally; Whitbread Sinks


UK EXECUTIVE CHANGE SUMMARY: Diageo Taps Former Bain And Goldman Exec